URGOSTART PLUS BORDER Hydrocellular adhesive dressing 13x15cm B/16

VIDAL
Parapharmacie
Updated on 20/11/2025

^CE URGOSTART^® PLUS BORDER

Presentation 

UrgoStart Plus Border is a very absorbent hydrocellular adhesive dressing with polyabsorbent fibers and TLC-NOSF matrix. Sterile and for single use.
Product manufactured in France.

Composition 

• Absorbent compress consisting of polyacrylate-based fibers, coated with TLC-NOSF technology (Lipido-Colloid Technology - Nano-Oligo Saccharide Factor). The TLC-NOSF technology is composed of liquid paraffin, sodium carboxymethylcellulose (CMC), potassium sucrose octasulfate (Nano-Oligo Saccharide Factor) and polymers.
  
• Super-absorbent inner layer made of cellulose and polymers.
  
• External support impermeable to water but allowing gas exchanges, coated with a silicone adhesive mass thanks to which the dressing is adhesive around the compress.
  

Properties 

Upon contact with exudates, the TLC-NOSF technology of UrgoStart Plus Border gels, which contributes to:

• limit the effect of enzymes called matrix metalloproteinases (MMPs) whose excess in chronic wounds delays healing ;
  
• maintain a moist environment favorable to healing.
  

The polyacrylate-based fibers facilitate:

• wound cleansing by trapping fibrin;
  
• stopping minor bleeding (hemostatic properties evaluated in vitro).
  

UrgoStart Plus Border:

• is easy to apply and is repositionable during its application;
  
• is flexible (adapts to the body area on which it is applied) and comfortable;
  
• is waterproof (allows showering) and to bacteria from the external environment;
  
• allows water vapor to pass through its backing;
  
• is atraumatic for the wound upon removal.
  

Indications 

UrgoStart Plus Border is indicated for covering and treating the following cutaneous wounds:

• Leg ulcers.
  
• Diabetic foot wounds.
  
• Pressure ulcers.
  
• Other wounds at risk of long-term healing, recurrent wounds, or wounds at risk of delayed healing.
  

UrgoStart Plus Border is intended to be used for all phases of healing: both on wounds covered with fibrin and on wounds covered with granulation tissue.
 
Targeted patients:
Adult patients, including notably elderly persons.
In the absence of specific data, UrgoStart Plus Border is not indicated in children nor in pregnant or breastfeeding women.

Directions for use 

• Prepare the wound according to the usual care protocol while respecting hygiene and asepsis conditions (hand disinfection or washing with soap and water, or wearing sterile gloves).
  
• When debridement is deemed necessary by the caregiver, the use of UrgoStart Plus Border does not replace it.
  The wound may appear larger after debridement or fibrin removal.
  
• Dry the skin around the wound with a sterile compress.
  
• Check that the pouch has not been damaged or inadvertently opened before use. If such is the case, use another one.
  
• Open the pouch and take UrgoStart Plus Border.
  
• UrgoStart Plus Border comprises several absorbent layers which must not be cut. Only the adhesive border may be cut with sterile scissors.
  
• Remove one of the two protective films, begin applying the dressing, and remove the second protective film.
  
• Apply the dressing making sure that its adhesive part is positioned at least one centimeter (1 cm) from the edges of the wound.
  Sacrum format: place the tip of the dressing at the start of the intergluteal fold.
  
• When compressive treatment is prescribed, apply the compression system.
  When offloading of the foot is prescribed or recommended, implement the offloading system.
  
• It is recommended to renew UrgoStart Plus Border every 1 to 2 days for wounds covered with fibrin, then to adapt the frequency of renewal according to the clinical state of the wound and the quantity of exudates, without exceeding 7 days of application.
  
• It is recommended to continue treatment with UrgoStart Plus Border until complete healing.
  

Contraindications 

• Wounds with fragile peri-lesional skin.
  
• Wounds of mucous membranes.
  
• Cancerous wounds.
  
• Fistulous wounds.
  
• Wounds of epidermolysis bullosa.
  
• Necrotic wounds.
  
• Bleeding wounds: UrgoStart Plus Border may be used to facilitate the stopping of minor bleeding but must not be used as a surgical sponge.
  
• Known patient hypersensitivity to one of the dressings with TLC or TLC-NOSF matrix, or to carboxymethylcellulose (CMC).
  

Precautions for use 

• In case of signs or symptoms of infection before or during the use of UrgoStart Plus Border, such as erythema, edema, heat or pain at the wound level, fever, enlargement of the wound, odor from the wound, or abundant exudates, consult a healthcare professional so that they can treat this infection at their convenience.
  
• In case of hypergranulation before or during the use of UrgoStart Plus Border, this must be reported to a healthcare professional for appropriate management.
  

STORAGE CONDITIONS 

Store UrgoStart Plus Border away from light.

ADMINISTRATIVE INFORMATION 

Medical device class IIb. BSI 2797.

Laboratoires URGO - Medical Division
42, rue de Longvic. BP 157. 21304 Chenôve cdx
Tel: 03 80 54 50 00. Fax: 03 80 44 74 52
www.urgomedical.fr